TickerFacts.

A business in context

CADL research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-30 · 0001193125-26-412658

  2. 4 · Ownership change

    Report date 2026-09-30 · 0001193125-26-412655

  3. 4 · Ownership change

    Report date 2026-09-30 · 0001193125-26-412654

  4. 4 · Ownership change

    Report date 2026-09-10 · 0001873905-26-000002

  5. 4 · Ownership change

    Report date 2026-09-08 · 0001193125-26-387924

  6. 8-K · Current report

    Report date 2026-09-06 · 0001193125-26-387310 · Items 5.02,7.01,9.01

  7. 8-K · Current report

    Report date 2026-09-09 · 0001193125-26-386561 · Items 7.01,9.01

  8. 4 · Ownership change

    Report date 2026-08-17 · 0001923794-26-000004

  9. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-347980

  10. 8-K · Current report

    Report date 2026-08-13 · 0001193125-26-347957 · Items 2.02,9.01

  11. 4 · Ownership change

    Report date 2026-07-06 · 0002139479-26-000004

  12. 4 · Ownership change

    Report date 2026-06-30 · 0001979825-26-000006

  13. 8-K · Current report

    Report date 2026-06-23 · 0001841387-26-000009 · Items 5.07

  14. 8-K · Current report

    Report date 2026-06-12 · 0001841387-26-000007 · Items 5.02,9.01

  15. 8-K · Current report

    Report date 2026-05-15 · 0001193125-26-226751 · Items 7.01,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-222904

  17. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-222892 · Items 2.02,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-06-23 · 0001193125-26-191506

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-103134

  20. 8-K · Current report

    Report date 2026-03-12 · 0001193125-26-103126 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2026-02-19 · 0001193125-26-062490 · Items 1.01,8.01,9.01

  22. 8-K · Current report

    Report date 2026-02-19 · 0001193125-26-059334 · Items 1.01,2.02,7.01,8.01,9.01

  23. 8-K · Current report

    Report date 2025-12-05 · 0001193125-25-308719 · Items 7.01,9.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-279086

  25. 8-K · Current report

    Report date 2025-11-13 · 0001193125-25-279072 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-10-14 · 0001193125-25-238254 · Items 1.01,2.02,2.03,3.02,7.01,8.01,9.01

  27. 8-K · Current report

    Report date 2025-08-18 · 0000950170-25-110682 · Items 1.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-108450

  29. 8-K · Current report

    Report date 2025-08-14 · 0000950170-25-108448 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-06-23 · 0001193125-25-145405 · Items 1.01,7.01,9.01

  31. 8-K · Current report

    Report date 2025-06-20 · 0001193125-25-144204 · Items 5.02,7.01,9.01

  32. 8-K · Current report

    Report date 2025-06-17 · 0000950170-25-087696 · Items 5.07

  33. 8-K · Current report

    Report date 2025-06-04 · 0000950170-25-082705 · Items 5.02,7.01,9.01

  34. 8-K · Current report

    Report date 2025-05-28 · 0000950170-25-078079 · Items 7.01,8.01,9.01

  35. 8-K · Current report

    Report date 2025-05-22 · 0000950170-25-076458 · Items 7.01,9.01

  36. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-069833

  37. 8-K · Current report

    Report date 2025-05-13 · 0000950170-25-069826 · Items 2.02,9.01

  38. DEF 14A · Proxy statement

    Report date 2025-06-17 · 0000950170-25-060093

  39. 8-K · Current report

    Report date 2025-04-23 · 0000950170-25-057398 · Items 7.01,9.01

  40. 8-K · Current report

    Report date 2025-03-26 · 0001193125-25-064374 · Items 7.01,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 5 transaction rows5SGrant / award: 5 transaction rows5AExercise / conversion: 2 transaction rows2MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

12 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-11
2026-09-11
Tak Paul PeterS · Sale
Disposed
Common Stock59379.010.46
2026-09-10
2026-09-11
Tak Paul PeterM · Exercise / conversion
Acquired
Common Stock125000.01.55
2026-09-10
2026-09-11
Tak Paul PeterS · Sale
Disposed
Common Stock220866.011.5
2026-09-10
2026-09-11
Tak Paul PeterM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
125000.00.0
2026-09-08
2026-09-10
Zimmermann MartineA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
64000.00.0
2026-08-17
2026-08-19
Tyagarajan SeshuS · Sale
Disposed
Common Stock7000.012.0
2026-07-06
2026-07-08
Sims Mark E.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
285000.00.0
2026-06-30
2026-07-01
Loggia NicolettaA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
381.08.64
2026-06-30
2026-07-01
Manning Paul BA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
2199.08.64
2026-06-30
2026-07-01
PAPA JOSEPH CA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1331.08.64
2026-06-29
2026-07-01
Tyagarajan SeshuS · Sale
Disposed
Common Stock7000.010.02
2026-06-29
2026-07-01
Barone FrancescaS · Sale
Disposed
Common Stock23447.010.06

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001841387Candel Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2022-12-31$125.0K$143.9K
    2021-12-31$125.0K$155.4K
    2020-12-31$125.0K$162.7K

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗